Literature DB >> 10981596

The role of generic health-related quality of life measures in establishing audiological rehabilitation outcomes.

F H Bess1.   

Abstract

OBJECTIVE: To review the status of generic functional health measures used with hearing-impaired adults and to summarize the findings of studies that have utilized these outcome measures to assess the benefit of amplification.
DESIGN: Four basic generic quality of life measures used with the hearing-impaired population for determining hearing aid benefit are reviewed and discussed. The measures include the Sickness Impact Profile, the Self Evaluation of Life Function, the Medical Outcomes Study, and the Dartmouth COOP Functional Health Assessment Charts.
RESULTS: The review of studies concerned with quality of life measures revealed that present day functional health status tools lack the necessary sensitivity to detect clinically meaningful improvements in patients with hearing impairment.
CONCLUSIONS: Although we have good reason to believe that hearing aids improve quality of life, available functional health status measures lack the appropriate sensitivity to be used for assessing the benefit of amplification in individuals with hearing impairment. There is an urgent need for additional research to address this important area.

Entities:  

Mesh:

Year:  2000        PMID: 10981596     DOI: 10.1097/00003446-200008001-00009

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  16 in total

Review 1.  Guidelines for Best Practice in the Audiological Management of Adults with Severe and Profound Hearing Loss.

Authors:  Laura Turton; Pamela Souza; Linda Thibodeau; Louise Hickson; René Gifford; Judith Bird; Maren Stropahl; Lorraine Gailey; Bernadette Fulton; Nerina Scarinci; Katie Ekberg; Barbra Timmer
Journal:  Semin Hear       Date:  2020-12-16

Review 2.  Health-related quality of life and hearing aids: a tutorial.

Authors:  Harvey B Abrams; Theresa H Chisolm; Rachel McArdle
Journal:  Trends Amplif       Date:  2005

3.  The WHO-DAS II: measuring outcomes of hearing aid intervention for adults.

Authors:  Rachel McArdle; Theresa H Chisolm; Harvey B Abrams; Richard H Wilson; Patrick J Doyle
Journal:  Trends Amplif       Date:  2005

4.  The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss.

Authors:  Theresa H Chisolm; Harvey B Abrams; Rachel McArdle; Richard H Wilson; Patrick J Doyle
Journal:  Trends Amplif       Date:  2005

5.  From the editor. The Desired Sensation Level (DSL) method for fitting hearing aids.

Authors:  Benjamin Hornsby
Journal:  Trends Amplif       Date:  2005

Review 6.  Comparative studies on hearing aid selection and fitting procedures: a review of the literature.

Authors:  Mick Metselaar; Bert Maat; Hans Verschuure; Wouter A Dreschler; Louw Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-23       Impact factor: 2.503

7.  Development and psychometric evaluation of a health-related quality of life instrument for individuals with adult-onset hearing loss.

Authors:  Carren J Stika; Ron D Hays
Journal:  Int J Audiol       Date:  2016-04-22       Impact factor: 2.117

8.  Self-report outcome measures for adult hearing aid services: some uses, users, and options.

Authors:  S Gatehouse
Journal:  Trends Amplif       Date:  2001-09

9.  The Baltimore HEARS Pilot Study: An Affordable, Accessible, Community-Delivered Hearing Care Intervention.

Authors:  Carrie L Nieman; Nicole Marrone; Sara K Mamo; Joshua Betz; Janet S Choi; Kevin J Contrera; Roland J Thorpe; Laura N Gitlin; Elizabeth K Tanner; Hae-Ra Han; Sarah L Szanton; Frank R Lin
Journal:  Gerontologist       Date:  2017-11-10

10.  Development and validation of the Zurich chronic middle ear inventory (ZCMEI-21): an electronic questionnaire for assessing quality of life in patients with chronic otitis media.

Authors:  David Bächinger; Christof Röösli; Beate Ditzen; Alexander M Huber
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.